GRANDI, GIOVANNI
 Distribuzione geografica
Continente #
NA - Nord America 5.922
EU - Europa 2.574
AS - Asia 1.180
AF - Africa 33
OC - Oceania 19
SA - Sud America 19
Continente sconosciuto - Info sul continente non disponibili 1
Totale 9.748
Nazione #
US - Stati Uniti d'America 5.904
GB - Regno Unito 650
IT - Italia 590
SE - Svezia 480
CN - Cina 390
HK - Hong Kong 327
DE - Germania 275
SG - Singapore 200
UA - Ucraina 116
FI - Finlandia 104
BG - Bulgaria 95
TR - Turchia 72
IN - India 44
NL - Olanda 44
RU - Federazione Russa 43
ID - Indonesia 33
FR - Francia 31
MY - Malesia 24
IE - Irlanda 23
LT - Lituania 22
ET - Etiopia 20
AU - Australia 19
IR - Iran 16
PL - Polonia 16
IQ - Iraq 15
VN - Vietnam 13
ES - Italia 12
IS - Islanda 11
BE - Belgio 9
BR - Brasile 9
JP - Giappone 9
CA - Canada 8
CZ - Repubblica Ceca 8
IL - Israele 8
MX - Messico 8
LV - Lettonia 6
PH - Filippine 6
PT - Portogallo 6
RS - Serbia 6
CH - Svizzera 4
KZ - Kazakistan 4
MD - Moldavia 4
RO - Romania 4
CM - Camerun 3
CO - Colombia 3
DK - Danimarca 3
EC - Ecuador 3
GR - Grecia 3
KR - Corea 3
PK - Pakistan 3
SI - Slovenia 3
AR - Argentina 2
AT - Austria 2
CL - Cile 2
GE - Georgia 2
HU - Ungheria 2
JO - Giordania 2
KE - Kenya 2
QA - Qatar 2
SA - Arabia Saudita 2
SN - Senegal 2
TH - Thailandia 2
TN - Tunisia 2
UG - Uganda 2
AE - Emirati Arabi Uniti 1
BH - Bahrain 1
BZ - Belize 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EG - Egitto 1
EU - Europa 1
MK - Macedonia 1
NO - Norvegia 1
TW - Taiwan 1
Totale 9.748
Città #
Fairfield 927
Chandler 646
Ashburn 562
Southend 495
Woodbridge 465
Seattle 350
Nyköping 346
Cambridge 329
Hong Kong 325
Houston 325
Wilmington 277
Jacksonville 219
Dearborn 207
Ann Arbor 193
Beijing 142
Singapore 141
Modena 138
Princeton 120
San Diego 96
Sofia 95
New York 79
Bremen 71
Helsinki 62
Eugene 55
Milan 41
Izmir 37
Shanghai 34
London 33
Jakarta 30
Redwood City 26
Rome 25
Dublin 23
Bologna 22
Dronten 18
Norwalk 18
San Mateo 16
Orsogna 15
Baghdad 14
Falls Church 14
San Giuliano Milanese 13
Grafing 12
Guangzhou 12
Kraków 12
Dong Ket 10
Hafnarfjordur 10
Boardman 9
Kilburn 9
Amsterdam 8
Chiswick 8
Jinan 8
Munich 8
Brussels 7
Hefei 7
Kunming 7
Lappeenranta 7
Napoli 7
Piacenza 7
Prescot 7
Tehran 7
Brno 6
Chicago 6
Dongguan 6
Esslingen am Neckar 6
Hounslow 6
Madrid 6
Melbourne 6
Mumbai 6
Riga 6
Stockholm 6
Turin 6
Washington 6
Acton 5
Belgrade 5
Gunzenhausen 5
Jinhua 5
Meppel 5
Mykolayiv 5
Omaha 5
Phoenix 5
Rimini 5
Venice 5
Zola Predosa 5
Andover 4
Berlin 4
Chisinau 4
Frankfurt am Main 4
Fuzhou 4
Hebei 4
Mantova 4
Monmouth Junction 4
Monza 4
Padova 4
Parma 4
Pittsburgh 4
Raipur 4
San Francisco 4
San Jose 4
Southwark 4
Sydney 4
Tokyo 4
Totale 7.405
Nome #
Estradiol in hormonal contraception: real evolution or just same old wine in a new bottle? 229
The Association between Endometriomas and Ovarian Cancer: Preventive Effect of Inhibiting Ovulation and Menstruation during Reproductive Life 198
Intermenstrual pelvic pain, quality of life and mood 194
Adenomyosis of the Extrapelvic Portion of the Round Ligament 184
Combined Hormonal Contraceptive Use and Risk of Breast Cancer in a Population of Women With a Family History 182
Intensity of menstrual pain and estimated angle of uterine flexion 181
Metabolic impact of combined hormonal contraceptives containing estradiol 180
Hereditary Ovarian Cancer: Not Only BRCA 1 and 2 Genes 179
Impact of laparoscopic cystectomy of endometriotic and non-endometriotic cysts on ovarian volume, antral follicle count (AFC) and ovarian doppler velocimetry 176
Reproductive risk factors in women with family history of breast cancer attending an Italian Family Cancer Clinic 168
The association between progestins, nuclear receptors expression and inflammation in endometrial stromal cells from women with endometriosis 168
Prospective measurement of blood pressure and heart rate over 24 h in women using combined oral contraceptives with estradiol 168
A regional audit system for stillbirth: A way to better understand the phenomenon 168
Levonorgestrel-releasing intra-uterine systems as female contraceptives 167
Body composition and resting metabolic rate of perimenopausal women using continuous progestogen contraception 164
Pharmacokinetic evaluation of desogestrel as a female contraceptive 162
Evaluation of Transvaginal Ultrasound plus CA-125 Measurement and Prophylactic Salpingo-Oophorectomy in Women at Different Risk Levels of Ovarian Cancer: The Modena Study Group Cohort Study 161
Association between urinary incontinence and climacteric symptoms in postmenopausal women 161
Pelvic Pain and Quality of Life of Women With Endometriosis During Quadriphasic Estradiol Valerate/Dienogest Oral Contraceptive. A Patient-Preference Prospective 24-Week Pilot Study 158
Combined hormonal contraceptives in BRCA gene mutation carriers: why not? 156
Effect of oral contraceptives containing estradiol and nomegestrol acetate or ethinyl-estradiol and chlormadinone acetate on primary dysmenorrhea 155
Brca detection rate in an italian cohort of luminal early-onset and triple-negative breast cancer patients without family history: When biology overcomes genealogy 153
Prevalence of menstrual pain in young women: what is dysmenorrhea 148
Progestin suppressed inflammation and cell viability of tumor necrosis factor-α-stimulated endometriotic stromal cells 145
Inflammation influences steroid hormone receptors targeted by progestins in endometrial stromal cells from women with endometriosis 141
Dienogest mediates midkine suppression in endometriosis 141
Modification of body composition and metabolism during oral contraceptives containing non-androgenic progestins in association with estradiol or ethinyl estradiol 140
The Jellyfish Sign: A New Sonographic Cervical Marker to Predict Maternal Morbidity in Abnormally Invasive Placenta Previa 139
The impact of reproductive life on breast cancer risk in women with family history or BRCA mutation 137
Vaginal alpha-lipoic acid shows an anti-inflammatory effect on the cervix, preventing its shortening after primary tocolysis. A pilot, randomized, placebo-controlled study 136
Induction of Labor According to Medical Indications: A Critical Evaluation through a Prospective Study 134
Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 133
Increasing BMI is associated with both endometrioid and serous histotypes among endometrial rather than ovarian cancers: a case-to-case study 128
Hereditary ovarian cancers: State of the art 125
Easy tools to screen Italian women suffering from migraine with and without aura in early reproductive age 116
A comprehensive review of hormonal and biological therapies for endometriosis: latest developments 112
Postmenopausal hormone therapy in BRCA gene mutation carriers: to whom and which? 103
Hormonal contraception in women with endometriosis: a systematic review 98
Dienogest-based hormonal contraception induced changes in the ultrasound presentation of the uterus and menstrual pain 95
Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers 94
Use of hormonal contraception in italian university students 91
Carboplatin-paclitaxel in triple-negative metastatic breast cancer during pregnancy with neoplastic thrombosis 90
Eziologia del dolore pelvico cronico e qualità di vita. 87
BRCA mutation carriers' perceptions on postmenopausal hormone therapy: An Italian study 87
Surface roughness of different contraceptive vaginal rings: evaluation by scanning electron microscope (SEM) 86
Attitudes of women towards products containing hormones (hormonal contraceptives or hormone therapy): what changes from pre to postmenopause? 85
The generally low sensitivity of CA125 for FIGO stage I ovarian cancer diagnosis increases for endometrioid histotype 84
Current and future hormonal contraception in Italy: results from an Italian consensus expert meeting 84
The reduction of CA 125 serum levels in BRCA 1/2 mutation carriers after risk-reducing salpingo-oophorectomy is only partially associated with surgery: A prospective cohort, other biomarker controlled, study 81
Hormonal Contraception in perimenopausal women 75
Estetrol (E4): the new estrogenic component of combined oral contraceptives 75
Satisfaction with prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers is very high and little dependent on the participants' characteristics at surgery: a prospective study 75
The paradigm of norgestimate: a third-generation testosterone-derivative progestin with a peripheral anti-androgenic activity and the lowest risk of venous thromboembolism 75
Soluzioni di design per viti di connessione implantare: studio agli elementi finiti. 74
Estradiol in non-oral hormonal contraception: a “long and winding road” 74
The impact of COVID-19 lockdown on admission to gynecological emergency departments: Results from a multicenter Italian study 68
Prevalenza e caratteristiche del dolore mestruale in giovani donne 66
Prevalenza e fattori di rischio di dismenorrea in studentesse universitarie italiane 65
Primary fallopian tube carcinoma (PFTC) in a BRIP-1 mutation carrier: the first case report 65
Contemporary prescriptions pattern of different dose levonorgestrel-releasing intrauterine systems in an Italian service for family planning 65
Sintomi della menopausa; conseguenze a breve e a lungo termine. 63
Trattamento medico dell'endometriosi: progestinici e formulazioni estro-progestiniche 61
Drospirenone 4 mg-only pill (DOP) in 24+4 regimen: a new option for oral contraception 60
Short-term effects of metformin and myo-inositol in women with polycystic ovarian syndrome (PCOS): a meta-analysis of randomized clinical trials 59
The gendered impact of coronavirus disease (COVID-19): do estrogens play a role? 59
A first trimester prediction model for large for gestational age infants: a preliminary study 58
Molecole di adesione tissutale ed endometriosi 57
Lipid metabolism, insulin resistance, blood pressure and body composition with oral contraceptives containing astradiol valerato/dienogest vs ethinylestradiol/chlormadinone: a prospective, randomized trial. 57
Future directions in endometriosis treatment: discovery and development of novel inhibitors of estrogen biosynthesis 57
Fattori di rischio cardiovascolare, dolore mestruale e qualità di vita con contraccettivi orali contenenti estradiolo valerato/dienogest vs etinilestradiolo/clormadinone acetato: trial prospettico, randomizzato. 56
Prophylactic risk-reducing salpingo-oophorectomy in BRCA mutation carriers: what is going on in a region of northern Italy? 56
Differenze nell’espressione delle molecole di adesione tissutale in donne affette da endometriosi 55
Miglioramento della qualità di vita con contraccettivo orale in donne affette da dismenorrea primaria 55
Wide diameter immediate post-extractive implants vs delayed placement of normal-diameter implants in preserved sockets in the molar region: 1-year post-loading outcome of a randomised controlled trial 55
Breast cancer screening of mutation carriers in the era of COVID-19 pandemic 55
A 10-year report from a multicentre randomised controlled trial: Immediate non-occlusal versus early loading of dental implants in partially edentulous patients 52
Planning familiare e rischio di endometriosi in donne con dolore pelvico cronico 50
The use of different doses levonorgestrel-releasing intrauterine system (LNG-IUS): real-world data from a multicenter Italian study 50
Vitamin D and green tea extracts for the treatment of uterine fibroids in late reproductive life: a pilot, prospective, daily-diary based study 49
Contraception during Coronavirus-Covid 19 pandemia. Recommendations of the Board of the Italian Society of Contraception 48
The challenging screen detection of ovarian cancer in BRCA mutation carriers adhering to a 6-month follow-up program: results from a 6-years surveillance 47
It is time to talk about replacement of subdermal implants from the same cut, is it always feasible? The slow process of the "armpit approach" 47
The Association of Four Natural Molecules-EGCG, Folic Acid, Vitamin B12, and HA-To Counteract HPV Cervical Lesions: A Case Report 46
Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA 45
The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study 45
Combined oral contraceptive with estetrol plus drospirenone: from pharmacokinetics to clinical applications 44
BRCA mutation carriers’ perception about benefits and risks associated with combined hormonal contraceptives use 42
Immediate loading of two unsplinted implants retaining the existing complete mandibular denture in elderly edentulous patients: 1-year results from a multicentre prospective cohort study 42
Potentially preventable antepartum stillbirths in a high-resource setting: a prospective audit-based study 40
Immediate, early (3 weeks) and conventional loading (4 months) of single implants: Preliminary data at 1 year after loading from a pragmatic multicenter randomised controlled trial 39
Contraception and Cardiovascular Diseases 39
One abutment-one time versus a provisional abutment in immediately loaded post-extractive single implants: A 1-year follow-up of a multicentre randomised controlled trial 38
Attitudes towards menstruation: what women want? An Italian National Survey 37
Implant site preparation using a single bur versus multiple drilling steps: 4-month post-loading results of a multicenter randomised controlled trial 37
A comparison of two implants with conical vs internal hex connections: 1-year post-loading results from a multicentre, randomised controlled trial 37
Clinical outcome and bone healing of implants placed with high insertion torque: 12-month results from a multicenter controlled cohort study 37
The difficult journey to treatment for women suffering from heavy menstrual bleeding: a multi-national survey 35
PET/CT guided surgical excision of small abdominal wall metastases in morbidly obese endometrial cancer patients 34
Immediate loading of four (all-on-4) post-extractive implants supporting mandibular cross-arch fixed prostheses: 18-month follow-up from a multicentre prospective cohort study 30
Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer 29
Totale 9.531
Categoria #
all - tutte 59.015
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.015


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.415 0 0 72 82 140 265 276 150 145 101 130 54
2020/20211.925 141 77 88 201 258 128 128 203 129 213 134 225
2021/20221.592 187 97 77 37 46 138 34 76 260 166 238 236
2022/20231.985 280 265 137 144 223 270 42 153 235 38 99 99
2023/20241.623 68 86 62 162 270 133 159 216 99 82 106 180
2024/2025219 138 81 0 0 0 0 0 0 0 0 0 0
Totale 9.952